Related Experiment Video
Updated: Mar 16, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update
Ajay K Chaudhary1, Shruti Chaudhary, Kanjaksha Ghosh
1Department of Immunohematology, National Institute of Immunohematology, KEM Hospital Campus, Parel, Mumbai, India
Abstract:
Controlled remodeling of the extracellular matrix (ECM) is essential for cell growth, invasion and metastasis. Matrix metalloproteinases (MMPs) are a family of secreted, zincdependent endopeptidases capable of degradation of ECM components. The expression and activity of MMPs in a variety of human cancers have been intensively studied. They play important roles at different steps of malignant tumor formation and have central significance in embryogenesis, tissue remodeling, inflammation, angiogenesis and metastasis. However, increasing evidence demonstrates that MMPs are involved earlier in tumorigenesis. Recent studies also suggest that MMPs play complex roles in tumor progression. MMPs and membrane type (MT)MMPs are potentially significant therapeutic targets in many cancers, so that designing of specific MMP inhibitors would be helpful for clinical trials. Here, we review the pleiotropic roles of the MMP system in hematological malignancies invitro and invivo models.
Insights
Matrix metalloproteinases (MMPs) are key enzymes in cancer progression and metastasis. This review explores the diverse roles of MMPs in hematological malignancies, highlighting their potential as therapeutic targets.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Extracellular matrix (ECM) remodeling is crucial for cell functions like growth and metastasis.
- Matrix metalloproteinases (MMPs) are enzymes that degrade ECM components.
- MMPs are implicated in various stages of cancer, from early tumorigenesis to metastasis.
Purpose of the Study:
- To review the multifaceted roles of the MMP system in hematological malignancies.
- To highlight the significance of MMPs and membrane type MMPs (MT-MMPs) as therapeutic targets.
Main Methods:
- Literature review of in vitro and in vivo studies on MMPs in hematological malignancies.
Main Results:
- MMPs play complex and varied roles in tumor progression.
- Evidence suggests MMPs are involved early in tumorigenesis.
- MMPs and MT-MMPs are significant therapeutic targets in many cancers.
Conclusions:
- The MMP system has pleiotropic roles in hematological malignancies.
- Targeting MMPs offers potential therapeutic strategies for blood cancers.
More Related Videos
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mesenchymal Stem Cells

